Literature DB >> 33902643

Is podocytopathy another image of renal affection in p-SLE?

Hend H Abdelnabi1.   

Abstract

BACKGROUND: Lupus podocytopathy (LP) is a renal affection described in systemic lupus erythematosus (SLE) patients with nephrotic range proteinuria, characterized by diffuse foot process effacement without immune deposits and glomerular proliferation. This study describes LP, its pathological features and outcomes of pediatric (p-SLE) patients in comparison to the usual lupus nephritis (LN) cases.
METHODOLOGY: A retrospective cohort study conducted on a 10-year registration (2010-2019) of 140 p-SLE patients at the Pediatric Department, Tanta University. Histopathological analysis with light microscopy (LM) and immunofluorescence (IF) of all renal biopsies were evaluated according to the International Society of Nephrology Renal Pathology Society (ISN/RPS) grading system. In addition, some biopsies were examined with electron microscopy (EM).
RESULTS: Eighty-six p-SLE cases (61.4%) had renal involvement; seventy-nine biopsies (91.86%) of them met the classification criteria of LN as defined by ISN/RPS system. Five biopsies were normal (MCD) and two showed focal segmental sclerosis (FSGN) that did not meet any known classification of LN. Hence, they were reevaluated using EM that revealed diffuse effaced podocytes without glomerular sub-epithelial, endocapillary or basement membrane immune deposits, and were classified as having lupus podocytopathy, representing (8.14%) of all LN biopsies. Those seven cases showed good response to steroids with a complete remission duration of 3.40 ± 1.95 weeks. However, some case had 1-3 relapses during the duration of follow up.
CONCLUSIONS: LP is a spectrum of p-SLE, not an association as it is related to disease activity and its initial presentation.

Entities:  

Keywords:  Lupus nephritis; Pediatric systemic lupus erythematosus; Podocytopathy

Year:  2021        PMID: 33902643     DOI: 10.1186/s12969-021-00547-9

Source DB:  PubMed          Journal:  Pediatr Rheumatol Online J        ISSN: 1546-0096            Impact factor:   3.054


  14 in total

1.  Minimal change disease in systemic lupus erythematosus.

Authors:  G K Dube; G S Markowitz; J Radhakrishnan; G B Appel; V D D'Agati
Journal:  Clin Nephrol       Date:  2002-02       Impact factor: 0.975

2.  SLE and idiopathic nephrotic syndrome: coincidence or not?

Authors:  Alexandre Hertig; Dominique Droz; Philippe Lesavre; Jean-Pierre Grünfeld; Philippe Rieu
Journal:  Am J Kidney Dis       Date:  2002-12       Impact factor: 8.860

3.  EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs.

Authors:  G K Bertsias; J P A Ioannidis; M Aringer; E Bollen; S Bombardieri; I N Bruce; R Cervera; M Dalakas; A Doria; J G Hanly; T W J Huizinga; D Isenberg; C Kallenberg; J C Piette; M Schneider; N Scolding; J Smolen; A Stara; I Tassiulas; M Tektonidou; A Tincani; M A van Buchem; R van Vollenhoven; M Ward; C Gordon; D T Boumpas
Journal:  Ann Rheum Dis       Date:  2010-08-19       Impact factor: 19.103

4.  Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children.

Authors:  L A Ramírez Gómez; O Uribe Uribe; O Osio Uribe; H Grisales Romero; M H Cardiel; D Wojdyla; B A Pons-Estel; Luis J Catoggio; Enrique R Soriano; Patricia M Imamura; Jorge A Manni; Sebastián Grimaudo; Judith Sarano; José A Maldonado-Cocco; Maria S Arriola; Graciela Gómez; Mercedes A García; Ana Inés Marcos; Juan Carlos Marcos; Hugo R Scherbarth; Pilar C Marino; Estela L Motta; Cristina Drenkard; Susana Gamron; Sandra Buliubasich; Carlos M Onetti; Francisco Caeiro; Alejandro Alvarellos; Verónica Saurit; Silvana Gentiletti; Norberto Quagliatto; Alberto A Gentiletti; Daniel Machado; Marcelo Abdala; Simón Palatnik; Guillermo A Berbotto; Carlos A Battagliotti; Emilia Sato; Elaine M C Sella; AlexandreW S Souza; Lilian T Lavras Costallat; Manoel Barros Bertolo; Ibsen Bellini Coimbra; Eduardo Ferreira Borba Neto; Eloisa Bonfá; João Carlos Tavares; Ricardo Xavier; Tamara Mucenic; Fernando de Souza Cavalcanti; Angela Luzia Branco Duarte; Cláudia Diniz Lopes Marques; Nilzio Antonio Da Silva; Ana Carolina de O e Silva; Tatiana Ferracine Pacheco; José Fernando Molina-Restrepo; Javier Molina-López; Antonio Iglesias-Gamarra; Antonio Iglesias-Rodríguez; Eduardo Egea-Bermejo; Renato A Guzmán-Moreno; José F Restrepo-Suárez; Marlene Guibert-Toledano; Gil Alberto Reyes-Llerena; Loreto Massardo; Néstor Gareca; Sergio Jacobelli; Oscar J Neira; Leonardo R Guzmán; Abraham Garcia-Kutzbach; Claudia Castellanos; Erwin Cajas; Virginia Pascual-Ramos; Leonor A Barile-Fabris; Juan Manuel Miranda-Limón; Mary-Carmen Amigo; Luis H Silveira; Ignacio García De La Torre; Gerardo Orozco-Barocio; Magali L Estrada-Contreras; Maria Josefina Sauza del Pozo; Laura E Aranda Baca; Adelfia Urenda Quezada; Guillermo F Huerta-Yáñez; Eduardo M Acevedo-Vásquez; José Luis Alfaro-Lozano; Jorge M Cucho-Venegas; Maria Inés Segami; Cecilia P Chung; Magaly Alva-Linares; Isaac Abadi; Rosa Chacón-Díaz; Soham Al Snih Al Snih; Maria H Esteva-Spinetti; Jorge Vivas
Journal:  Lupus       Date:  2008-06       Impact factor: 2.911

5.  Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study.

Authors:  B Bader-Meunier; J B Armengaud; E Haddad; R Salomon; G Deschênes; I Koné-Paut; T Leblanc; C Loirat; P Niaudet; J C Piette; A M Prieur; P Quartier; F Bouissou; M Foulard; G Leverger; I Lemelle; P Pilet; M Rodière; N Sirvent; P Cochat
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406

6.  Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis.

Authors:  T S Han; M M Schwartz; E J Lewis
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 7.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

8.  Systemic lupus erythematosus in Egyptian children.

Authors:  Samia Salah; Hala Mohamed Lotfy; Samar M Sabry; Azza El Hamshary; Heba Taher
Journal:  Rheumatol Int       Date:  2009-03-20       Impact factor: 2.631

9.  Glomerular podocytopathy in patients with systemic lupus erythematosus.

Authors:  Steven W Kraft; Melvin M Schwartz; Stephen M Korbet; Edmund J Lewis
Journal:  J Am Soc Nephrol       Date:  2004-11-17       Impact factor: 10.121

Review 10.  A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus.

Authors:  Nicki Tiffin; Adebowale Adeyemo; Ikechi Okpechi
Journal:  Orphanet J Rare Dis       Date:  2013-01-07       Impact factor: 4.123

View more
  1 in total

1.  Lupus podocytopathy and antiphospholipid syndrome in a child with SLE: A case report and literature review.

Authors:  Guo-Min Li; Yi-Fan Li; Qiao-Qian Zeng; Xiao-Mei Zhang; Hai-Mei Liu; Jia-Yan Feng; Yu Shi; Bing-Bing Wu; Hong Xu; Li Sun
Journal:  Front Pediatr       Date:  2022-08-19       Impact factor: 3.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.